share

Gsk-3 β Inhibitor 2 CAS NO 1702428-31-6


Unit Price:

CAS No.:1702428-31-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Gsk-3 β Inhibitor 2 CAS NO 1702428-31-6 is a potent and selective small molecule inhibitor of glycogen synthase kinase-3 beta (GSK-3β), a serine/threonine kinase involved in numerous critical cellular signaling pathways. This compound is a vital research tool for investigating the role of GSK-3β in diseases such as neurological disorders, diabetes, and cancer. It is primarily utilized by pharmaceutical R&D teams, academic researchers, and biotechnology companies engaged in drug discovery and molecular biology studies.

Application

  • Biochemical Research: A key reagent for in vitro enzymatic assays to study GSK-3β kinase activity and inhibition kinetics.
  • Cell-Based Studies: Used to probe Wnt/β-catenin, insulin, and other signaling pathways in cultured cell lines to understand disease mechanisms.
  • Drug Discovery & Development: Serves as a reference compound or lead molecule in high-throughput screening (HTS) campaigns and structure-activity relationship (SAR) studies for novel therapeutics.
  • Neuroscience Research: Investigated for its potential neuroprotective effects in models of Alzheimer's disease, bipolar disorder, and other CNS conditions.
  • Metabolic Disease Research: Applied in studies focusing on insulin resistance, glucose metabolism, and type 2 diabetes.
  • Oncology Research: Explored for its role in modulating apoptosis and cell proliferation in various cancer cell models.

Basic Information

Item Detail
Product Name Gsk-3 β Inhibitor 2
CAS No. 1702428-31-6
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms GSK-3β Inhibitor 2; GSK-3β Inhibitor II; GSK-3β Inhibitor 2 (CAS 1702428-31-6); GSK-3β Inhibitor; Glycogen Synthase Kinase-3 Beta Inhibitor 2; 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile; (S)-6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-4,5-dihydro-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile
EINECS Contact for details

Quality Control

Our Gsk-3 β Inhibitor 2 is produced under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. All materials are characterized using advanced analytical techniques, including NMR and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and other critical parameters is provided with every shipment to support your research documentation and compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under desiccated conditions. This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability and potency. Allow the vial to equilibrate to room temperature before opening to minimize moisture ingress.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms
Identification (MS) Conforms
Purity (HPLC) ≥95%
Water Content (KF) ≤1.0%
Solubility Soluble in DMSO, DMF

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.